This topic contains a solution. Click here to go to the answer

Author Question: For which common side effects should you monitor after administering any anti-Parkinson's drug to a ... (Read 33 times)

Mollykgkg

  • Hero Member
  • *****
  • Posts: 529
For which common side effects should you monitor after administering any anti-Parkinson's drug to a patient?
 
  a. Dizziness and hypotension
  b. Diarrhea and nausea
  c. Hypertension and headache
  d. Body rash and elevated temperature

Question 2

Which precaution should you teach patients prescribed carbidopa-levodopa (Sinemet)?
 
  a. Avoid crowds and people who are ill.
  b. Take this drug with an antacid to prevent ulcers.
  c. Restrict your fluid intake to less than 1.5 L daily.
  d. Keep the bottle containing the drug in the refrigerator.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

epscape

  • Sr. Member
  • ****
  • Posts: 335
Answer to Question 1

ANS: A

Answer to Question 2

ANS: A




Mollykgkg

  • Member
  • Posts: 529
Reply 2 on: Jul 23, 2018
Wow, this really help


apple

  • Member
  • Posts: 352
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Amoebae are the simplest type of protozoans, and are characterized by a feeding and dividing trophozoite stage that moves by temporary extensions called pseudopodia or false feet.

Did you know?

Vaccines prevent between 2.5 and 4 million deaths every year.

Did you know?

In 1864, the first barbiturate (barbituric acid) was synthesized.

Did you know?

People who have myopia, or nearsightedness, are not able to see objects at a distance but only up close. It occurs when the cornea is either curved too steeply, the eye is too long, or both. This condition is progressive and worsens with time. More than 100 million people in the United States are nearsighted, but only 20% of those are born with the condition. Diet, eye exercise, drug therapy, and corrective lenses can all help manage nearsightedness.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library